Literature DB >> 8723589

Consensus statement: using epoetin alfa to decrease the risk of allogeneic blood transfusion in the surgical setting. Roundtable of Experts in Surgery Blood Management.

K Messmer1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8723589

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  5 in total

1.  Clinical outcomes with use of erythropoiesis stimulating agents in patients with the HeartMate II left ventricular assist device.

Authors:  Michael E Nassif; Jayendrakumar S Patel; Jerrica E Shuster; David S Raymer; Ronald Jackups; Eric Novak; Brian F Gage; Sunil Prasad; Scott C Silvestry; Gregory A Ewald; Shane J LaRue
Journal:  JACC Heart Fail       Date:  2015-02       Impact factor: 12.035

2.  Alternative procedures for reducing allogeneic blood transfusion in elective orthopedic surgery.

Authors:  Kathrin Kleinert; Oliver M Theusinger; Johannes Nuernberg; Clément M L Werner
Journal:  HSS J       Date:  2010-01-28

3.  [Jehova's Witnesses and severe injury with impending hemorrhaging : how complex is the treatment?].

Authors:  C Zeckey; N Vanin; G Neitzke; P Mommsen; S Bachmann; M Frink; M Wilhelmi; C Krettek; F Hildebrand
Journal:  Chirurg       Date:  2011-06       Impact factor: 0.955

4.  Cost effectiveness of epoetin-alpha to augment preoperative autologous blood donation in elective cardiac surgery.

Authors:  D Coyle; K M Lee; D A Fergusson; A Laupacis
Journal:  Pharmacoeconomics       Date:  2000-08       Impact factor: 4.981

5.  Epoetin alfa in Pediatric Patients With Ventricular Assist Devices: Is It Safe?

Authors:  Kaitlynn Hughes; Audrey Jarosz; David M Peng; Ashley Huebschman
Journal:  J Pediatr Pharmacol Ther       Date:  2022-05-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.